Legend Biotech

CIK 0001801198 · LEGN Nasdaq

SIC
2834 · Pharmaceutical Preparations
Status
Public
FY End
Dec 31

About Legend Biotech

LEGEND BIOTECH CORPORATION is an SEC registrant, classified under SIC 2834 (Pharmaceutical Preparations). It files with the SEC under Central Index Key 0001801198, and its shares are listed as LEGN on Nasdaq. Its most recent filing on EDGAR is a 4, filed November 16, 2026. 197 institutional investment managers reported holding its shares on Form 13F for Q3 2026, against 220 in Q2 2026. Its officers, directors and 10% owners have filed 15 Form 4 reports since 2026. 1 investor reports a stake of 5% or more on Schedule 13D or 13G. It reported about $270,000 of federal lobbying in the four quarters through Q3 2026.

Across SEC filings

Institutional holders · 13F

Q3 2026
197 managers reported a position for Q3 2026 -23 vs Q2 2026
Largest Q3 2026 Form 13F holders of Legend Biotech by reported value
Largest holders Reported value
FMR LLC $481.3M
Kynam Capital Management LP $182.1M
HHLR ADVISORS LTD $166.3M
DEERFIELD MANAGEMENT COMPANY L P SERIES C $161.9M
SUVRETTA CAPITAL MANAGEMENT LLC $123.9M

5%+ holders · 13D/G

1 filer
Schedule 13D and 13G filers reporting a stake of 5% or more
Filer % of class Filed
FMR LLC 13G 12.4% 2026-11-05

Latest Schedule 13D or 13G from each filer; stakes a filer has reported closed are left out.

Securities

Securities issued by this company
CUSIP Security Type
52490G102 LEGN LEGEND BIOTECH CORP-ADR Adr

Insider trades · Form 4

-$384K net open-market insider transactions, last 12 months 1 filing with purchases ($183K), 5 filings with sales ($567K)

Latest filings

Federal lobbying · LD-2

$270.0K reported spend, four quarters through Q3 2026

Latest SEC filings

All filings →
Latest SEC filings by Legend Biotech
Form Description Filed
4 Insider Transaction · Peter Salovey 2026-11-16
6-K Foreign Current Report 2026-11-10
SCHEDULE 13G/A SCHEDULE 13G/A 2026-11-05
6-K Foreign Current Report 2026-11-04
6-K Foreign Current Report 2026-10-15
6-K Foreign Current Report 2026-10-13
S-8 Employee Plan Registration 2026-10-07
4 Insider Transaction · (corsee) D. Sanders Corazon 2026-10-01
144 144 2026-09-29
4 Insider Transaction · Peter Salovey 2026-09-28
Loading ownership data...
Loading insider trading data...
Loading financials...

Quality is a Plus feature

See why the score is what it is — the score history and the full test-by-test breakdown behind the composite.

Valuation is a Premium feature

What this company is worth versus its price — fair value at today's bond rate, margin of safety, and the Graham Number against the institutional consensus price.

Loading SEC filings...
Loading sponsor profile...